Cureline AG belongs to Cureline Group, precision medicine CRO of Californian origin and global reach. In 20 years of its history, Cureline Group became a best-in-class expert in oncology human sample validation studies (HBS biobanking), in vitro and animal testing. New venture: ATMP CDMO (EU).

Products, services, technology

oncology human sample validation studies (HBS biobanking) - in vitro testing and animal testing - preclinical models - gene and cell therapy (as of 2024) - concierge services along the whole process of drug development (with our partner in clinical space, Wiesbaden based company palleos)

Cooperation possibilities

Our R&D areas include gene and cell therapy, exosome research, 3D organoids. We are interested in discussing possible collaborations also in those areas. We welcome investors to join efforts on innovative CRO equity solutions, gene and cell therapy development.

Some insights
Facts & figures
  • Type of organization
    Private company
  • Year of foundation
  • Number of employees in Switzerland

You may also be interested in